IFL – Buying Support Returns

IFL has caught our attention again after yesterday’s strong price performance following a number of research houses upgrading the earnings outlook.

The upgrades are supported by aggressive cost savings, post the acquisition of the ANZ advice business.

We’re not convinced IFL is a long-term buy and hold but with the recent upgrades we may see buying momentum create another leg higher in the “higher low” price formation.

We recommend running a stop loss below the recent low.

Medibank – Private Valuation Review

If we assume FY18 NPAT of $440m, (up 4% on FY17), and $0.12 per share in dividends, Medibank Private is now 20x FY18 earnings on a forward dividend yield of 4.3%.

Medibank continues to drive industry wide reforms, although growth appears limited due to ongoing affordability concerns.

We recommend selling at the money covered call options into June to enhance the yield, whilst keeping exposure to the March dividend.

 

 

Lendlease – Finding Support Near $15.50

Our Algo Engine generated a buy signal in Lendlease back in October.  Since then the stock has moved down to find buying support at $15.50.

LLC is in the ASX 50 model and we expect buying support will soon see  the share price recapture $17 in the weeks ahead.

Place a stop-loss order on a  break back below $15.50.

Lendlease